Christoph K. Naber

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial

Lansky AJ, Xu B, Baumbach A, Kelbæk H, van Royen N, Zheng M, Knaapen P, Slagboom T, Johnson TW, Vlachojannis GJ, Arkenbout KE, Holmvang L, Janssens L, Brugaletta S, Naber CK, Schmitz T, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina CM, Buszman PE, Thiele H, Schächinger V, Wijns W

December 4, 2023 | 10.4244/EIJ-D-23-00409

How to set up regional STEMI networks: a "Stent - Save a life!" initiative

Candiello A, Alexander T, Delport R, Toth GG, Ong P, Snyders A, Belardi J, Lee M, Pereira H, Mohamed A, Mayol J, Piek J, Wijns W, Baumbach A, Naber CK

March 18, 2022 | 10.4244/EIJ-D-21-00694

Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Chieffo A, Tarantini G, Naber CK, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D

February 19, 2021 | 10.4244/EIJ-D-20-01291

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek J, Spitzer E, Jüni P, Hamm C, Steg G, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018

Barbato E, Mauri Ferre J, Byrne RA, Roffi M, Fitzsimons D, Toth GG, Capodanno D, Mehilli J, Petronio AS, Chieffo A, Vardas P, Naber CK, Dudek D, Haude M, Baumbach A

April 16, 2019 | 10.4244/EIJV14I17A297

Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial

Jensen C, Richardt G, Tölg R, Erglis A, Skurk C, Jung W, Neumann F, Stangl K, Brachmann J, Fischer D, Mehilli J, Rieber J, Wiemer M, Schofer J, Sack S, Naber CK

November 20, 2018 | 10.4244/EIJ-D-17-01079

Impact of left atrial appendage morphology on indication and procedural outcome after interventional occlusion: results from the prospective multicentre German LAARGE registry

Fastner C, Naber CK, Nienaber C, Park J, Brachmann J, Zeymer U, Goedde M, Sievert H, Geist V, Lewalter T, Krapivsky A, Kaunicke M, Maier J, Ozdemir B, Hochadel M, Schneider S, Senges J, Akin I

June 20, 2018 | 10.4244/EIJ-D-17-00866

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber CK, Urban P, Ong P, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef H, Wiebe J, Kastner J, Mehilli J, Munzel T, Naber CK, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00330

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Munzel T, Nef H, Naber CK, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00291

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Munzel T, Capranzano P, Di Mario C, Naber CK, Araszkiewicz A, Colombo A, Caramanno G, Sabaté M, Tamburino C, Nef H, Gori T

October 11, 2017 | 10.4244/EIJ-D-16-00568

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber CK, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Munzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis

Naber CK, Pyxaras S, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, den Heijer P, Schillinger W, Scholtz S, Van Der Heyden JA, Lefèvre T, Gilard M, Kuck K, Schofer J, Divchev D, Baumgartner H, Asch FM, Wagner M, Latib A, De Marco F, Kische S

December 9, 2016 | 10.4244/EIJ-D-15-00511

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabaté M, Mattesini A, Geraci S, Naber CK, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Munzel T

August 5, 2016 | 10.4244/EIJY15M09_10

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber CK

August 5, 2016 | 10.4244/EIJV12I5A102

Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study

Naber CK, Pyxaras S, Nef H, IJsselmuiden AJ, Briguori C, Schlundt C, Wykrzykowska JJ, Eberli F, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns R, Bouchez D, Mudra H

June 20, 2016 | 10.4244/EIJY15M06_02

Transapical valve-in-valve TAVI in a patient with two failing surgical bioprostheses with Edwards SAPIEN 3 valves using a cerebral protection system

Wolf A, Schmitz T, Bigdeli H, Naber CK

March 18, 2016 | 10.4244/EIJV11I12A274

Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis

Naber CK, Pyxaras S, Ince H, Latib A, Frambach P, den Heijer P, Wagner M, Butter C, Colombo A, Kische S

February 12, 2016 | 10.4244/EIJV11I11A254

Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial

Thomas M, Nienaber C, Naber CK, Ince H, Erglis A, Vukcevic V, Schäfer U, Ferreira R, Hardt S, Verheye S, Ribeiro V, Sugeng L, Tamburino C

October 20, 2015 | 10.4244/EIJV11I6A143

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

Wöhrle J, Naber CK, Schmitz T, Schwenke C, Frey N, Butter C, Brachmann J, Ingwersen M, Drabik A, Markovic S, Mathey D

June 19, 2015 | 10.4244/EIJY14M12_10

Christoph K. Naber

Latest news